AlphaYou
Overview
Smart money at a glance
Filings to Sep 30, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 4 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 29- Open
- $10.04
- 52-wk high
- $20.46
- High
- $10.19
- 52-wk low
- $7.21
- Low
- $9.89
- Prev close
- $10.12
- Mkt cap
- $2.27B
- P/E
- 14.5x
- Volume
- 3.46M
- Fwd P/E
- 9.8x
- Beta
- 0.77
- P/S
- 4.4x
- P/B
- 5.3x
- Profit margin
- +33.0%
- Op margin
- +42.2%
- ROE
- +41.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ADMA filings
Are insiders buying or selling ADMA Biologics Inc (ADMA) stock?
Neither. ADMA Biologics Inc (ADMA) insiders filed no open-market purchases or sales in the 90 days to Sep 30, 2026, according to SEC Form 4 filings.
Which members of Congress have traded ADMA recently?
None. No member of Congress disclosed a ADMA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ADMA smart-money data?
This summary uses filings available on Sep 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (1)
- DS
D.E. Shaw
$39.1M
added
Sells/Trims (2)
- CI
Citadel
$40.9M
trimmed
- P7
Point72
$26.2M
trimmed
What insiders are doing
Buys (3)
- GJ
Grossman Jerrold B
$51K
bought
- GJ
Grossman Jerrold B
$100K
bought
- GJ
Grossman Jerrold B
$100K
bought
How top traders are positioned
No tracked top-trader positions in ADMA right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
$0.16 expected
Reports Nov 4, 2026, in 35 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $134.2M | $139.2M | $114.5M | $124.4M |
| Cost of what it sold | $58.6M | $50.3M | $33.7M | $38.1M |
| Gross profit | $75.6M | $88.8M | $80.8M | $86.3M |
| What it spent | ||||
| Research and development | $1.5M | $1.4M | $2.6M | $6.0M |
| Sales and admin | $21.8M | $23.5M | $26.7M | $26.7M |
| Other operating costs | $1.3M | $1.2M | $1.1M | $1.1M |
| Total operating expenses | $24.6M | $26.1M | $30.4M | $33.8M |
| What was left | ||||
| Operating profit | $51.0M | $62.8M | $50.3M | $52.4M |
| Interest on debt | $1.7M | $1.6M | $2.1M | $3.4M |
| Profit before tax | $47.5M | $61.6M | $57.1M | $50.2M |
| Tax | $11.1M | $12.2M | $11.8M | $12.4M |
| Net profit | $36.4M | $49.4M | $45.3M | $37.8M |
| EBITDA | $51.2M | $65.3M | $61.1M | $57.3M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Macro
33 macro signals shaping ADMA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results